Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus
NCT04532541 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-03-08
Summary
The purpose of this study is to unravel the proportion of monogenic lupus in children onset Systemic lupus erythematosus (SLE), and to find out the diagnostic strategy for early detection of monogenic lupus.
Conditions
- Monogenic Lupus
- Systemic Lupus Erythematosus
Interventions
- OTHER
-
Monogenic lupus screening
This is an observational study, and there is no intervention. This study intends to obtain the incidence of monogenic lupus in childhood onset SLE through gene test and bioinformatic analysis.
Sponsors & Collaborators
-
Children's Hospital of Fudan University
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-25
- Primary Completion
- 2025-09-30
- Completion
- 2025-09-30
Countries
- China
Study Locations
More Related Trials
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
NCT06151990 ·Status: RECRUITING
-
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
NCT05247203 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus
NCT05687526 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Outcomes in SLE at Peking University People's Hospital
NCT07005479 ·Status: RECRUITING
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)
NCT06675422 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients
NCT07183007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
NCT00876616 ·Status: COMPLETED ·Phase: NA
-
Interdisciplinary Study Group of Lupus Erythematosus (ISGLE)
NCT00420173 ·Status: COMPLETED
-
ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
NCT07314567 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Health-related Quality of Life Measure in Pediatric Lupus
NCT00280137 ·Status: COMPLETED
-
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310 ·Status: RECRUITING ·Phase: PHASE3
-
LUpus Eritematoso Sistemico NETwork and Registry
NCT07175610 ·Status: NOT_YET_RECRUITING
-
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus
NCT00556192 ·Status: COMPLETED ·Phase: PHASE2
-
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
NCT06791772 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
NCT04305197 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
NCT02453997 ·Status: COMPLETED
-
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus
NCT04293510 ·Status: UNKNOWN
-
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
NCT04908865 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
NCT06718283 ·Status: RECRUITING
-
Efficacy and Safety of Telitacicept in Early SLE
NCT05899907 ·Status: UNKNOWN ·Phase: PHASE4
-
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
NCT04702256 ·Status: RECRUITING ·Phase: PHASE3
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN